Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer

Cisplatin-based chemoradiation is the standard treatment for cervical cancer, but chemosensitizing strategies are needed to improve patient survival. EGFR (Epidermal Growth Factor Receptor) is an oncogene overexpressed in cervical cancer that is involved in chemoresistance. Recent studies showed tha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Hugo de Almeida, Vitor, Guimarães, Isabella dos Santos, Almendra, Lucas R., Rondon, Araci M.R., Tilli, Tatiana M., de Melo, Andréia C., Sternberg, Cinthya, Monteiro, Robson Q.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078136/
https://ncbi.nlm.nih.gov/pubmed/30093972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25748
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados